Advancement in New Drug Discovery for Treatment of Hepatitis

The current existing treatments eliminates the virus in only a little more than half of all patients. Those drugs may also have unwanted side effects which makes it difficult for patients to take them. In recent years, tremendous research advances are transforming on treatment of Hepatitis. This progress has occurred in just last three years with new and effective therapies transforming the trajectory of the disease for many patients. The scientific advances that are made by biopharmaceutical researchers have already begun to have a tangible impact on thousands of patients. In all these areas, rapid progress is being made and more new medicines are on the way. The Food and Drug Administration has approved a new drug named Harvoni, which combines sofosbuvir and ledipasvir which cures Hepatitis C virus in just eight weeks.

    Related Conference of Advancement in New Drug Discovery for Treatment of Hepatitis

    November 28-29, 2024

    12th Annual Congress on Pulmonary and Critical Care

    Paris, France
    May 14-15, 2025

    4th World Summit on COPD

    Barcelona, Spain

    Advancement in New Drug Discovery for Treatment of Hepatitis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in